Swiss Re proposes to elect Jay Ralph and Joerg Reinhardt to the Board

23 February 2017 — Vlad BOLDIJAR
Swiss Re Group announced that the Board of Directors proposes to elect Jay Ralph and Joerg Reinhardt as new, non-executive and independent members at the Annual General Meeting of shareholders on 21 April 2017. At the same time, as it had already announced, Swiss Re also proposes to elect Jacques de Vaucleroy to its Board of Directors. Carlos E. Represas, who has been a member of Swiss Re's Board since 2010, will not stand for re-election.

Jay Ralph was most recently a member of the Board of Management of Allianz SE and Chairman at Allianz Asset Management. His prior roles at Allianz include CEO of Allianz Re within Allianz SE, Munich and CEO of Allianz Risk Transfer, Zurich. He started his career at Arthur Andersen & Company, Chicago and went on to Northwestern Mutual Life Insurance Company, Milwaukee and Centre Re Bermuda Ltd, Bermuda before joining Allianz. Jay Ralph is an American and Swiss citizen and was born in 1959. He holds an MBA in Finance and Economics from the University of Chicago and a BBA in Finance and Accounting from the University of Wisconsin. He is also a Certified Public Accountant (CPA) and a Chartered Financial Analyst (CFA).

Joerg Reinhardt has been the Chairman of the Board of Directors of Novartis since 2013. He is also Chairman of the Board of Trustees of the Novartis Foundation. Previously, he was Chairman of the Board of Management and the Executive Committee of Bayer HealthCare, Germany. He was also a member of the Supervisory Board of MorphoSys AG in Germany and a member of the Board of Directors of Lonza Group AG in Switzerland. Reinhardt joined Sandoz Pharma Ltd. in 1982 and held various senior positions at Sandoz and later Novartis, including Head of Development and Chief Operating Officer. He is a German citizen and was born in 1956. He graduated with a doctorate in pharmaceutical sciences from Saarland University in Germany.

2166 views
Share |